Akebia Therapeutics (NASDAQ:AKBA) Price Target Increased to $5.00 by Analysts at HC Wainwright
Akebia Therapeutics (NASDAQ:AKBA – Free Report) had its price objective hoisted by HC Wainwright from $3.75 to $5.00 in a research report report published on...
ADTRAN (NASDAQ:ADTN) Upgraded by StockNews.com to Sell
StockNews.com upgraded shares of ADTRAN (NASDAQ:ADTN – Free Report) to a sell rating in a research report released on Friday morning. Several other brokerages have...
NatWest Group (LON:NWG) Upgraded at Barclays
Barclays upgraded shares of NatWest Group (LON:NWG – Free Report) to an overweight rating in a report released on Friday, Marketbeat reports. They currently have...
Babcock International Group (LON:BAB) Rating Increased to Overweight at Barclays
Barclays upgraded shares of Babcock International Group (LON:BAB – Free Report) to an overweight rating in a research report report published on Friday, Marketbeat.com reports....
Coherus BioSciences (NASDAQ:CHRS) Research Coverage Started at Robert W. Baird
Robert W. Baird began coverage on shares of Coherus BioSciences (NASDAQ:CHRS – Free Report) in a research note published on Friday, MarketBeat Ratings reports. The...
Expedia Group (NASDAQ:EXPE) Upgraded to “Outperform” by Evercore ISI
Evercore ISI upgraded shares of Expedia Group (NASDAQ:EXPE – Free Report) from an in-line rating to an outperform rating in a research note published on...